BVF PARTNERS L P/IL - 10%+ Owner at Eledon Pharmaceuticals, Inc.

Issuer-level insider activity

Role: 10%+ Owner
Issuer ticker: ELDN on Nasdaq
Entity type: Company
Source filing history: Open source filing history

No buys or sells have been reported by BVF PARTNERS L P/IL since 28 Sep 2025

Reported holdings for BVF PARTNERS L P/IL in Eledon Pharmaceuticals, Inc.

Form 4 holding 10%+ Owner

Eledon Pharmaceuticals, Inc.

Security class: Pre-funded Warrants to Purchase Common Stock
Shares / value: 838,507
Estimated value: $3,059,712
Report date: 29 Oct 2024
Price: $3.65
Ownership: Direct
Underlying class: Common Stock, $0.001 par value
Underlying amount

Form 4 holding 10%+ Owner

Eledon Pharmaceuticals, Inc.

Security class: Common Stock, $0.001 par value
Shares / value: 220,460
Estimated value: $987,661
Report date: 29 Oct 2024
Price: $4.48
Ownership: Direct

Form 4 holding 10%+ Owner

Eledon Pharmaceuticals, Inc.

Security class: Warrants to Purchase Common Stock
Shares / value: 252,291
Estimated value
Report date: 29 Oct 2024
Price
Ownership: Direct
Underlying class: Common Stock, $0.001 par value
Underlying amount: 252,291

Form 4 holding 10%+ Owner

Eledon Pharmaceuticals, Inc.

Security class: Series X1 Convertible Preferred
Shares / value: 7,635
Estimated value
Report date: 29 Oct 2024
Price
Ownership: Direct
Underlying class: Common Stock, $0.001 par value
Underlying amount: 424,169

Form 4 holding 10%+ Owner

Eledon Pharmaceuticals, Inc.

Security class: Series X Convertible Preferred
Shares / value: 346
Estimated value
Report date: 29 Oct 2024
Price
Ownership: Direct
Underlying class: Common Stock, $0.001 par value
Underlying amount: 19,222

Form 4 holding 10%+ Owner

Eledon Pharmaceuticals, Inc.

Security class: Warrants to Purchase Series X1 Convertible Preferred Stock
Shares / value: 189
Estimated value
Report date: 29 Oct 2024
Price
Ownership: Direct
Underlying class: Series X1 Convertible Preferred Stock, $0.001 par value
Underlying amount: 189,000

Transaction history for BVF PARTNERS L P/IL in Eledon Pharmaceuticals, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .